Published online Mar 28, 2021. doi: 10.3748/wjg.v27.i12.1117
Peer-review started: December 21, 2020
First decision: January 10, 2021
Revised: January 19, 2021
Accepted: March 11, 2021
Article in press: March 11, 2021
Published online: March 28, 2021
Core Tip: In 2020, the landmark series of accomplishments which started with the discovery of the hepatitis C virus (HCV) and led to the development of pharmaceutical agents capable of curing HCV infection was underscored by the awarding of the Nobel Prize in Medicine. These innovative cures are now being applied to the pediatric population. Furthermore, programs such as The Kentucky Hepatitis Academic Mentorship Program have been developed to train general pediatricians on HCV epidemiology, diagnosis, management, treatment and prevention. Thus this cascade of care will hopefully help achieve the World Health Organization goal of eliminating HCV by 2030.